News Releases

The unprecedented effort yielded nearly one million potential antibiotic compounds, with dozens showing promising activity in initial tests against disease-causing bacteria.

An exhalation delivery system that uses a patient’s own breath to carry an anti-inflammatory directly to the sinuses reduced chronic sinus infection symptoms in two Phase III clinical trials.

Findings indicate the potential for monitoring disease risk through inexpensive, unintrusive continuous measures of skin temperature.

An experimental mRNA vaccine provides protection in preclinical animal models against infection from Borrelia burgdorferi, the bacteria that causes Lyme disease. Results suggest that the vaccine prevents the development of Lyme disease.

Penn Medicine and Penn Engineering expand presence in Wexford’s uCity Square Knowledge Community.

Penn researchers in the Berger Lab have found the blood-brain barrier (BBB) plays a significant role in controlling behavior critical to how ant colonies function. The implications of this research go beyond the world of ants.

An electron microscopy study revealed key details of actin filaments, which are essential structural elements of cells and muscles.

A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, & reduction in cellular toxicity. The approach could also power the development of advanced cell therapies for cancers and other diseases.